Related Experiment Video
Updated: Jul 5, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Course and therapy of acute liver failure
Ludger Leifeld1, Ph Merk, V Schmitz
1Department of Internal Medicine I, University of Bonn, Germany. l.leifeld@gmx.de
European Journal of Medical Research
|April 22, 2008
Summary
Fulminant hepatic failure (FHF) survival improved significantly between two study periods. Advances in therapy allowed more patients to survive without liver transplantation, highlighting improved FHF management.
Area of Science:
- Hepatology
- Transplantation Medicine
- Critical Care Medicine
Background:
- Fulminant hepatic failure (FHF) is a life-threatening condition despite advances in liver transplantation and intensive care.
- Clinical observations of FHF patient outcomes are infrequent.
- This study analyzes trends in FHF patient management and survival.
Purpose of the Study:
- To analyze the clinical course and survival rates of patients treated for FHF.
- To compare outcomes of FHF patients treated between 1998-2004 with those treated during 1992-1997.
- To identify factors contributing to changes in FHF patient survival.
Main Methods:
- Retrospective analysis of all FHF patients treated at the University of Bonn.
- Comparison of patient data from two distinct time periods (1992-1997 and 1998-2004).
- Evaluation of survival rates and transplantation necessity.
Main Results:
- 35 FHF patients were treated between 1998-2004, an increase from 16 patients in 1992-1997.
- 1-year survival improved from 67.5% to 80% over the study periods.
- A lower proportion of patients required liver transplantation (45% vs. 68%) in the later period, despite increased FHF incidence.
Conclusions:
- Advances in FHF therapy have led to improved patient survival.
- A greater percentage of FHF patients can now survive without requiring a liver transplant.
- The findings suggest evolving and more effective management strategies for FHF.
More Related Videos
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...